Product image of Levetiracetam Actavis (Levetiracetam) supplied by GNH India

Levetiracetam Actavis

Active Ingredient:
Levetiracetam
Origin:
EU

Levetiracetam Actavis (Levetiracetam)

Levetiracetam, the active ingredient in Levetiracetam Actavis, is an anticonvulsant presented as an oral tablet for oral use. It is prescribed to manage various seizure types, including partial, generalized tonic‑clonic, and myoclonic seizures, in adult and pediatric patients. It is available in several dosage strengths to allow individualized dosing based on clinical assessment.

GNH India supplies Levetiracetam Actavis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to WHO‑GMP guidelines and provides temperature‑controlled logistics where required.

Manufacturer / TM Owner

Actavis Group Ptc Ehf.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Levetiracetam is an anticonvulsant used to control seizure activity in epilepsy.
  • Partial seizures: reduces frequency and severity of focal onset seizures.
  • Generalized tonic‑clonic seizures: helps prevent convulsive episodes in patients with generalized epilepsy.
  • Myoclonic seizures: decreases sudden muscle jerks associated with myoclonic epilepsy.

How It Works

  • Levetiracetam binds to the synaptic vesicle protein SV2A, modulating neurotransmitter release. This interaction stabilizes neuronal membranes and reduces hyper‑excitability, thereby diminishing the propagation of epileptiform discharges. The precise downstream effects involve inhibition of calcium‑dependent exocytosis, contributing to its anticonvulsant activity without significant interaction with G‑protein‑coupled receptors.

Side Effects

Levetiracetam may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects

  • Dizziness: transient light‑headedness that may affect balance and coordination.
  • Fatigue: persistent tiredness that can reduce daily activity tolerance.
  • Headache: mild to moderate pain often relieved with simple analgesics.
  • Irritability: heightened agitation or mood swings observed in some patients.
  • Skin reactions: mild rash or itching that usually resolves without treatment.

Serious or Rare Side Effects

  • Severe allergic reactions: rash, swelling, or Stevens‑Johnson syndrome requiring immediate medical attention.
  • Mood alterations: depression, anxiety, or suicidal thoughts that should be promptly reported.
  • Blood disorders: neutropenia, thrombocytopenia, or other hematologic abnormalities observed in laboratory tests.

Precautions & Warnings

  • Before prescribing Levetiracetam, clinicians should consider several precautionary measures to ensure safe use.
  • Renal impairment: dose adjustment may be required based on creatinine clearance.
  • History of psychiatric disorders: monitor for mood changes or depressive symptoms.
  • Concomitant CNS depressants: assess additive sedation risk.
  • Pregnancy: potential risks are unknown; use only if benefit outweighs risk.
  • Lactation: unknown safety; consider alternative therapy.
  • Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture.

Avoid Interactions

Levetiracetam can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid)

  • Carbamazepine: may reduce levetiracetam plasma concentrations.
  • Phenobarbital: may decrease levetiracetam levels, reducing seizure control.

Moderate Interactions (Monitor Closely)

  • Alcohol: additive CNS depression may increase dizziness or sedation.
  • Other antiepileptic drugs: monitor for synergistic toxicity.
  • Oral contraceptives: levetiracetam may lower hormone levels, reducing contraceptive effectiveness.

Frequently Asked Questions

Levetiracetam Actavis is an antiepileptic medication indicated for the treatment of partial seizures, generalized tonic‑clonic seizures, and myoclonic seizures. It helps to reduce the frequency and severity of seizure episodes in both adult and pediatric patients diagnosed with epilepsy.

Levetiracetam exerts its effect by binding to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This binding stabilizes neuronal membranes, lowers neuronal excitability, and limits the spread of epileptiform activity, thereby providing seizure control.

The appropriate dose of Levetiracetam Actavis is determined by the prescribing healthcare professional based on the patient’s age, weight, renal function, seizure type, and response to therapy. Dosage regimens are individualized and should follow the prescriber’s instructions.

Safety data for levetiracetam in pregnancy and lactation are limited. The medication should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any temperature‑controlled requirements) and the necessary import documentation.

Levetiracetam differs from many traditional antiepileptics because it has a unique mechanism involving SV2A binding and generally exhibits fewer drug‑enzyme interactions. Compared with agents such as valproate or carbamazepine, it often has a more favorable side‑effect profile, but individual response varies and choice of therapy should be individualized.

Levetiracetam Actavis tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture and direct sunlight, and ensure the packaging remains tightly closed until use.

The medication is taken orally, usually as a tablet swallowed whole with water. It can be taken with or without food, and dosing intervals are typically twice daily, although the exact schedule is set by the prescribing clinician.

Serious risks include severe allergic reactions such as Stevens‑Johnson syndrome, significant mood alterations including depression or suicidal thoughts, and hematologic abnormalities like neutropenia or thrombocytopenia. Any of these symptoms require immediate medical evaluation.

Patients with known hypersensitivity to levetiracetam or any of its excipients should avoid the drug. Those with severe renal impairment must have dose adjustments, and individuals experiencing uncontrolled psychiatric conditions should be closely monitored or consider alternative therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levetiracetam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT